RVO
HomeMarketplace

Wenliang Dong

CEO

ORCA Therapeutics BV

Amsterdam, Netherlands

7 profile visitsDutch mission participant Biotech

Wen Dong (PhD, MBA): CEO at ORCA Therapeutics with 15+ years in oncology drug development from discovery to clinic. Expert in gene therapy, antibodies & CMC.

My organisation

ORCA Therapeutics BV

ORCA Therapeutics BV

Company

Den Bosch, Netherlands

ORCA Therapeutics is a clinical-stage Dutch biotech company developing best-in-class oncolytic gene therapies with enhanced anti-tumor properties. Based in Amsterdam, our proprietary engineered viruses not only selectively destroy cancer cells but uniquely transform "cold" tumors into "hot" tumors, dramatically enhancing immune system recognition and response. Highlights: Best-in-class oncolytic virus with superior anti-tumor efficacy Proven immune activation - converts immunologically "cold" tumors to "hot" Enhanced therapeutic properties beyond standard oncolytic approaches Demonstrated clinical efficacy in completed Phase I/II trials
Read more

About me

Skills

  • Scientific Leadership
  • Drug Development Strategy
  • Regulatory Affairs
  • Target Discovery & Validation
  • gene therapy
  • Antibody Therapeutics
  • QA (GLP/GMP)
  • translational research
  • Cross-functional Team Management

Interests

  • ImmunOncology
  • Biologics Innovation
  • NextGenTherapeutics
  • Biotech Partnerships
  • Strategic Collaborations
  • Venture Capital
  • AI in drug discovery
  • Scientific networking
  • thought leadership
  • Industry Insights
  • AI in Drug Development

Marketplace (2)